TipRanks
Advertisement
Advertisement
Is LXRX a Buy, Before Earnings?
PremiumPre-EarningsIs LXRX a Buy, Before Earnings?
2M ago
Is LXRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is LXRX a Buy, Before Earnings?
2M ago
Lexicon Pharmaceuticals: Advancing Cardiometabolic Pipeline and Phase 3 HCM Data Support Unchanged $6 Price Target and Buy Rating
Premium
Ratings
Lexicon Pharmaceuticals: Advancing Cardiometabolic Pipeline and Phase 3 HCM Data Support Unchanged $6 Price Target and Buy Rating
2M ago
Lexicon reports Q1 EPS 0c, consensus (4c)
PremiumThe FlyLexicon reports Q1 EPS 0c, consensus (4c)
4M ago
Lexicon Pharmaceuticals Secures New Hercules Term Loan Facility
Premium
Company Announcements
Lexicon Pharmaceuticals Secures New Hercules Term Loan Facility
5M ago
Lexicon Shareholders Approve New Equity Plans, Capital Increase
Premium
Company Announcements
Lexicon Shareholders Approve New Equity Plans, Capital Increase
5M ago
Lexicon announces results from post hoc analysis on data of sotagliflozin
PremiumThe FlyLexicon announces results from post hoc analysis on data of sotagliflozin
6M ago
Lexicon price target raised to $2.30 from $2.10 at Citi
Premium
The Fly
Lexicon price target raised to $2.30 from $2.10 at Citi
6M ago
Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones
Premium
Company Announcements
Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100